Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978)
12/2010
12/02/2010US20100305100 Methods for treating hepatitis c
12/01/2010EP2255829A2 Pharmaceutical composition for treatment of diseases associated with decrease in bone mass comprising EP4 agonist as active ingredient
12/01/2010CN101903363A 2-methylthioethyl-substituted heterocycles as feed additives
12/01/2010CN101898925A Green synthesis and industrialization method of chloro-substituted heterocyclic ring
11/2010
11/30/2010US7842839 Method for producing optically active cycloalkylidenebisoxazoline compound and intermediate thereof
11/30/2010US7842706 Pharmaceutical composition
11/30/2010CA2477208C Substituted phenylalkanoic acid derivatives and use thereof
11/30/2010CA2460682C Ester compound and medical use thereof
11/25/2010WO2010133180A1 Poly-iodo benzene compound, preparation method and use thereof
11/25/2010WO2010113182A8 Intermediates in the preparation of 1,4-diphenyl azetidinone
11/25/2010WO2010056585A3 Heteroaryl diamide compounds useful as mmp-13 inhibitors
11/25/2010US20100298558 Substituted dihydroazole compound and pest control agent
11/25/2010US20100298384 Novel oxazolidinone compounds as antiinfective agents
11/25/2010US20100298330 Haloallylamine inhibitors of ssao/vap-1 and uses therefor
11/25/2010US20100298301 Oxazole tyrosine kinase inhibitors
11/25/2010US20100298291 Fused bicyclic-substituted amines as histamine-3 receptor ligands
11/24/2010EP2252590A1 Substituted sulfonic acid amide compounds
11/24/2010CN101896475A Treatment of duchenne muscular dystrophy
11/24/2010CN101896474A Method of making ketals and acetals
11/24/2010CN101891696A Poly-iodo acromatic compound and preparation method and application thereof
11/23/2010US7838682 Glucagon-like peptide-1 receptor agonists, the preparation and the use of the same
11/23/2010US7838681 Synthesis of substituted heterocyclic compounds
11/23/2010US7838520 Inhibitors of histone deacetylase
11/23/2010CA2377309C Compounds for the modulation of ppar.gamma. activity
11/18/2010WO2010131881A2 Bifunctional organic chiral catalyst compound with superior stereoselectivity, method for preparing same, and method for preparing chiral amino acids from azlactone using same
11/18/2010WO2010039186A3 Benzoxazoles useful as faah modulators and uses thereof
11/18/2010US20100292317 Antimicrobial and radioprotective compounds
11/18/2010US20100292274 Haloalkyl heteroaryl benzamide compounds
11/18/2010US20100292241 3,5-substituted-1,3-oxazolidin-2-one derivatives
11/18/2010US20100292240 Sulfonamide compounds
11/18/2010CA2761876A1 Haloalkyl heteroaryl benzamide compounds
11/18/2010CA2758675A1 Novel oxazolidinone derivatives
11/17/2010EP2251324A1 Heteroaryl-alkylcarbamate compounds and their use as inhibitors of the faah enzyme
11/16/2010US7834190 Process for production of optically active-3-amino-2-hydroxypropionic cyclopropylamide derivatives and salts thereof
11/16/2010US7834189 Oxazolium cation and fluoroalkylsulfonate or fluoroalkylsulfonimide anions; solvents and catalysts
11/16/2010US7834054 Hydroxamates as therapeutic agents
11/16/2010CA2479084C Vdac regulator
11/16/2010CA2396824C Heteroaromatic carboxamide derivatives and their use as inhibitors of the enzyme ikk-2
11/11/2010WO2010129596A1 Pmk2 modulators for use in the treatment of cancer
11/11/2010WO2009143178A3 Pde10 inhibitors and related compositions and methods
11/11/2010US20100286404 pharmaceutical intermediates in the synthesis of ace-inhibitors and the use thereof
11/11/2010US20100286211 Oxazolidinone derivatives as antimicrobials
11/11/2010CA2760929A1 Pmk2 modulators for use in the treatment of cancer
11/11/2010CA2758302A1 Compounds and compositions comprising cdk inhibitors and methods for treatment of cancer
11/10/2010EP1874764B1 Imino-oxazolidines and use thereof as anticoagulants
11/10/2010CN101883760A Heteroaryl amides useful as inhibitors of voltage-gated sodium channels
11/10/2010CN101230048B 3-amido-2-oxazolidinone derivative hapten and method for preparing same
11/10/2010CN101031552B Photoactive 4,4-disubstituted oxazolidine derivative and its manufacturing method
11/09/2010US7829723 Polymorphic forms of (S)-1-cyanobutan-2-yl (S)-1-(3-3-(3-methoxy-4-(oxazol-5-yl)phenyl)uriedo)phenyl)ethylcarbamate
11/09/2010US7829705 such as 7-{2-[1-(6-methyl-3-pyridazinyl)-4-piperidinyl]ethoxy}-4-ethoxy-cinnoline, used in the treatment of picornavirus infections in humans
11/09/2010CA2530140C Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof
11/09/2010CA2434937C Phenyl derivatives
11/04/2010US20100280085 Chemical compounds
11/04/2010US20100280078 1-(Azolin-2-yl)amino-1,2-diphenylethane compounds for combating animal pests
11/04/2010US20100280073 Tricyclic inhibitors of hydroxysteroid dehydrogenases
11/04/2010US20100280036 Modulation of Pathogenicity
11/04/2010US20100280034 Modulation of pathogenicity
11/04/2010US20100279868 Novel herbicides
11/03/2010EP2245022A2 Antagonists of prostaglandin d2 receptors
11/03/2010EP2245019A1 4, 5-dihydro-oxazol-2-yl amine derivatives
11/03/2010EP1496838B1 Substituted amides
11/03/2010CN101328155B Oxazolidine derivates, preparation and application thereof
11/02/2010US7825260 (R)-2-amino-4-(2-benzo[1,3]dioxol-5-yl-benzoxazol-5-yl)-2-methyl-butan-1-ol; for the treatment or prevention of allo- or xenograft acute or chronic rejection or inflammatory or autoimmune disorders, or as a chemotherapeutic agent, e.g a malignant cell anti-proliferative agent
11/02/2010US7825145 Antimicrobial and radioprotective compounds
11/02/2010US7825144 chemical intermediates such as 2-(3-Methoxyphenyl)-4,5-dimethyloxazole 3-oxide, capable of being transformed to halomethyloxazoles smoothly with high yield and great purity
11/02/2010CA2389681C Npy y5 antagonist
10/2010
10/28/2010WO2010123139A1 Arylcarboxamide derivative having sulfamoyl group
10/28/2010WO2010122968A1 Diacylethylenediamine compound
10/28/2010WO2010078333A3 Benzoxazole-based fluorescent metal ion indicators
10/28/2010WO2009127338A8 Oxo-heterocyclic substituted carboxylic acid derivates and the use thereof
10/28/2010US20100274051 Inflammatory cytokine release inhibitor
10/28/2010US20100273842 Amine derivatives having npy y5 receptor antagonistic activity and the uses thereof
10/28/2010US20100273841 Amine-derivatives having npy y5 receptor antagonistic activity and the uses thereof
10/28/2010CA2759264A1 Diacylethylenediamine compound
10/27/2010CN1602290B Process for the synthesis of chirally pure beta -amino-alcohols
10/27/2010CN101111485B New haloalkylsulfonanilide derivative, herbicide and use method thereof
10/21/2010WO2010120741A1 Compositions and methods for modulating retinol binding to retinol binding protein 4 (rbp4)
10/21/2010WO2010118670A1 Dichloropropene compounds and uses thereof
10/21/2010US20100267961 Treatment of duchenne muscular dystrophy
10/21/2010US20100267945 Amine derivative having npy y5 receptor antagonistic activity
10/21/2010US20100267778 Diphenyl ether compound, process for producing the same, and use
10/21/2010US20100267714 Mif modulators
10/21/2010US20100267676 Gamma-amino-butyric acid derivatives as gabab receptor ligands
10/21/2010CA2758587A1 Compositions and methods for modulating retinol binding to retinol binding protein 4 (rbp4)
10/20/2010EP1924570B1 Azole and thiazole derivatives and their use
10/20/2010EP1780197B1 5-substituted-2-phenylamino benzamides as mek inhibitors
10/20/2010CN101863851A Dichloropropylene compound and application thereof
10/20/2010CN101863850A Method for separating epigoitrin and S-goitrin in (R, S)-goitrin
10/19/2010US7816536 4-substituted and 7-substituted indoles, benzofurans, benzothiophenes, benzimidazoles, benzoxazoles, and benzothiazoles and methods for making same
10/19/2010US7816534 N-[3-(4-chlorophenyl)-2-(3-pyridyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists
10/19/2010US7816527 Quinazoline-containing kits for labeling aldehyde or ketone moieties
10/19/2010US7816408 (N-{5-[(4-chlorophenyl)thio]pentyl}-N-[(1R)-1-(1-naphthyl)ethyl]amine); mimics/blocks effect of extracellular calcium in parathyroid cells, juxtaglomerular/proximal tubule kidney cells, parafollicular thyroid cells, bone osteoclasts, keratinocytes or placental trophoblasts; hyperparathyroidism
10/19/2010US7816385 Dicarboxy compounds for use as drugs and receptors for proliferation
10/19/2010US7816379 Antibiotics with improved solubility, lower toxicity; potent antibacterial activity; includes torezolid phosphate
10/19/2010US7816376 Use as excitatory amino acid antagonists for combating neurodegenerative and cerebrovascular diseases, epilepsy, schizophrenia, Alzheimer's, Parkinson's or Huntington's disease, or psychoses; for example, 3-[4-(3,4-methylenedioxybenzyl)piperidino]-N-(2-oxo-2,3-dihydrobenzoxazol-6-yl)propionamide
10/14/2010WO2010117435A2 No-carrier-added nucleophilic [f-18] fluorination of aromatic compounds
10/14/2010WO2010117040A1 Five-membered heterocyclic compound
10/14/2010US20100261725 Compounds that modulate intracellular calcium
10/14/2010US20100261675 Fungicidal composition containing acid amide derivative
10/13/2010EP1902039B1 6-oxazol-4-ylmethoxy-alkoxymethyl substituted benzoic acid derivatives forming ppar ligands, methods for production and the use thereof in the form of drugs
1 ... 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 ... 210